Clin2
NCT07127042Possibly a fitRecruiting

Testing a drug to reduce bleeding during knee replacement

Total Knee Arthroplasty

Treatments studied

Part of Blood & lymphatic, Bones, joints & muscles clinical trials.

This trial tests an experimental drug called BT-114143 to see if it reduces bleeding during and after total knee replacement surgery. It may be a good option for people with osteoarthritis who are having their first knee replacement.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
270 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old
  • You have osteoarthritis in your knee and are scheduled for a total knee replacement
  • Your knee deformity is mild (bending or bowing less than 15-20 degrees)
  • You have not taken blood thinners (like aspirin, warfarin) in the week before surgery
  • You are not planning any other surgeries within the next month

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06894719Not yet recruiting· Phase 4
Tranexamic Acid After Knee Replacement Surgery

This study tests whether taking tranexamic acid (a medicine that helps prevent bleeding) after total knee replacement can reduce pain and the need for strong painkillers. You would take the medicine for up to 7 days after surgery and answer a few daily questions.

NCT06618820Enrolling by invitation· Phase 3
Extended tranexamic acid after knee replacement

This trial tests whether taking tranexamic acid (a medicine that helps blood clot) for several days after knee replacement surgery reduces bleeding and improves recovery. It may help patients who have a standard knee replacement and are not on blood thinners.

Germantown, Tennessee
NCT07494032Not yet recruiting
Extended Oral Tranexamic Acid After Knee Replacement

This trial tests if taking tranexamic acid (TXA) pills for a week after knee replacement surgery helps reduce bleeding and the need for blood transfusions. You may qualify if you are having a planned first-time knee replacement with spinal anesthesia and are already scheduled for standard care.

New York, New York
NCT06479161Recruiting· Phase 2
Oral tranexamic acid study for knee replacement patients

This trial tests if taking tranexamic acid (TXA) as a pill can reduce bleeding after total knee replacement surgery. It may help you if you have knee osteoarthritis and are scheduled for a first-time knee replacement.

Hartford, Connecticut
NCT07140523Recruiting· Phase 2
Testing a new blood thinner for knee replacement surgery

This study tests a new injection called SRSD107 to see if it prevents blood clots after knee replacement surgery, compared to a standard blood thinner (enoxaparin). It might be an option if you are having a planned knee replacement and are otherwise healthy.

Nové Město na Moravě
NCT07089251Recruiting· Phase 4
Epinephrine and tranexamic acid in knee replacement surgery

This study tests if using epinephrine and tranexamic acid together helps reduce bleeding and improve outcomes during knee replacement surgery. It may be a good fit if you are planning to have knee replacement and do not have certain medical conditions or allergies to these medicines.

Riyadh, Riyadh Region

Hear when a new Total Knee Arthroplasty trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.